Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;17(4):599-608.
doi: 10.1038/s44321-025-00191-w. Epub 2025 Jan 27.

Exposomics: a review of methodologies, applications, and future directions in molecular medicine

Affiliations
Review

Exposomics: a review of methodologies, applications, and future directions in molecular medicine

Melissa Wan et al. EMBO Mol Med. 2025 Apr.

Abstract

The exposome is the measure of all the exposures of an individual in a lifetime and how those exposures relate to health. Exposomics is the emerging field of research to measure and study the totality of the exposome. Exposomics can assist with molecular medicine by furthering our understanding of how the exposome influences cellular and molecular processes such as gene expression, epigenetic modifications, metabolic pathways, and immune responses. These molecular alterations can aid as biomarkers for the diagnosis, disease prediction, early detection, and treatment and offering new avenues for personalized medicine. Advances in high throughput omics and other technologies as well as increased computational analytics is enabling comprehensive measurement and sophisticated analysis of the exposome to elucidate their cumulative and combined impacts on health, which can enable individuals, communities, and policymakers to create programs, policies, and protections that promote healthier environments and people. This review provides an overview of the potential role of exposomics in molecular medicine, covering its history, methodologies, current research and applications, and future directions.

Keywords: Environmental Exposures; Exposomics; Omics; Risk Assessment.

PubMed Disclaimer

Conflict of interest statement

Disclosure and competing interests statement. XZ is a cofounder of Exposomics, Inc. MPS is a cofounder and scientific advisor of Crosshair Therapeutics, Exposomics, Filtricine, Fodsel, iollo, InVu Health, January AI, Marble Therapeutics, Mirvie, Next Thought AI, Orange Street Ventures, Personalis, Protos Biologics, Qbio, RTHM, SensOmics. MPS is a scientific advisor of Abbratech, Applied Cognition, Enovone, Jupiter Therapeutics, M3 Helium, Mitrix, Neuvivo, Onza, Sigil Biosciences, TranscribeGlass, WndrHLTH, Yuvan Research. MPS is a cofounder of NiMo Therapeutics. MPS is an investor and scientific advisor of R42 and Swaza. MPS is an investor in Repair Biotechnologies. All other authors declare no conflict of interest.

Figures

Figure 1
Figure 1. Molecular medicine and the exposomics.
The exposome describes the collective exposures from an individual’s general external environment (climate, urban, rural), the specific external environment (nutrition, pollutants, exercise, pathogens), and the internal environment, (immune response, oxidative stress, metabolites, microbiome). The exposomics studies the exposome and its impacts on health outcomes through environmental exposure measurements and molecular biological responses through (bio)monitoring and omics technologies, respectively.
Figure 2
Figure 2. Data integration in exposomics.
Exposomics is dependent on data from a number of high-throughput technologies as well as information from sensors, geospatial devices, and wearable and mobile devices. The data were then processed and analyzed by statistical and bioinformatic tools that can provide associations between exposures and biological responses.

References

    1. Aguilera J, Han X, Cao S, Balmes J, Lurmann F, Tyner T, Lutzker L, Noth E, Hammond SK, Sampath V et al (2022) Increases in ambient air pollutants during pregnancy are linked to increases in methylation of IL4, IL10, and IFNγ. Clin Epigenetics 14:40 - PMC - PubMed
    1. An R, Wang X (2023) Artificial intelligence applications to public health nutrition. Nutrients 15:4285 - PMC - PubMed
    1. Babu M, Lautman Z, Lin X, Sobota MHB, Snyder MP (2024) Wearable devices: implications for precision medicine and the future of health care. Annu Rev Med 75:401–415 - PubMed
    1. Bai B, Wise JF, Vodák D, Nakken S, Sharma A, Blaker YN, Brodtkorb M, Hilden V, Trøen G, Ren W et al (2024) Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma. Blood Cancer J 14:147 - PMC - PubMed
    1. Balshaw DM, Collman GW, Gray KA, Thompson CL (2017) The children’s health exposure analysis resource: enabling research into the environmental influences on children’s health outcomes. Curr Opin Pediatr 29:385–389 - PMC - PubMed

LinkOut - more resources